← Leaderboards
Anna Aldovini
Children'S Hospital Boston
$26,114,277
Attributed
$27,869,304
Total exposure
22
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$27,869,304 · 22
By mechanism
R01$23,425,127 · 8
R56$1,950,587 · 3
R21$1,449,352 · 3
P51$1,044,238 · 8
Top collaborators
- Dennis Larry Kolson6 shared
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsCellsInfectionMediatingImmune ResponseViral Load ResultPeripheral Blood Mononuclear CellDisease ProgressionVirusMacaca MulattaAnimalsMacacaViremiaT-LymphocyteResponseAids VaccinesVaccinesAcquired Immunodeficiency SyndromeVaccinationPrimatesRecombinantsAffectTransmission ProcessProteins
Grant awards (58)
Prophylactic oral vaccination for SIV and SHIV infections and AIDS prevention$460,793
R01 · FY2020 · DE · contact PI
Prophylactic oral vaccination for SIV and SHIV infections and AIDS prevention$798,424
R01 · FY2019 · DE · contact PI
Macrophage lineage SIV persistence and latency during suppressive ART in Macaques$221,250
R21 · FY2019 · AI · contact PI
Prophylactic oral vaccination for SIV and SHIV infections and AIDS prevention$747,799
R01 · FY2018 · DE · contact PI
Macrophage lineage SIV persistence and latency during suppressive ART in Macaques$265,500
R21 · FY2018 · AI · contact PI
Role of p38 MAPK activation in AIDS pathogenesis$860,699
R01 · FY2017 · AI · contact PI
Prophylactic oral vaccination for SIV and SHIV infections and AIDS prevention$803,313
R01 · FY2017 · DE · contact PI
Role of the GI microbiome in immune responses to oral SIV-DNA+SIV-polio Vaccine$881,569
R56 · FY2016 · AI · contact PI
Role of p38 MAPK activation in AIDS pathogenesis$860,742
R01 · FY2016 · AI · contact PI
Prophylactic oral vaccination for SIV and SHIV infections and AIDS prevention$768,180
R01 · FY2016 · DE · contact PI
Role of p38 MAPK activation in AIDS pathogenesis$864,769
R01 · FY2015 · AI · contact PI
Pathways of HIV neurodegeneration and dimethyl fumarate (DMF/MMF) neuroprotection$670,774
R01 · FY2015 · MH
Role of p38 MAPK activation in AIDS pathogenesis$881,950
R01 · FY2014 · AI · contact PI
Pathways of HIV neurodegeneration and dimethyl fumarate (DMF/MMF) neuroprotection$690,994
R01 · FY2014 · MH
In vivo suppression of SIV-mediated immune activation$216,742
R21 · FY2014 · AI · contact PI
Pathways of HIV neurodegeneration and dimethyl fumarate (DMF/MMF) neuroprotection$676,854
R01 · FY2013 · MH
Oral vaccination for AIDS prevention in rhesus macaques$437,504
R56 · FY2013 · DE · contact PI
In vivo suppression of SIV-mediated immune activation$260,610
R21 · FY2013 · AI · contact PI
Pathways of HIV neurodegeneration and dimethyl fumarate (DMF/MMF) neuroprotection$724,652
R01 · FY2012 · MH
Oral Vaccination for AIDS Prevention in Rhesus Macaques$541,002
R01 · FY2012 · DE · contact PI
Pathways of HIV neurodegeneration and dimethyl fumarate (DMF/MMF) neuroprotection$395,964
R01 · FY2012 · MH
Oral Vaccination for AIDS Prevention in Rhesus Macaques$655,327
R01 · FY2011 · DE · contact PI
Pathways of HIV neurodegeneration and dimethyl fumarate (DMF/MMF) neuroprotection$350,816
R01 · FY2011 · MH
SIV DNA VACCINES AND MUCOSAL IMMUNITY$68,415
P51 · FY2011 · RR · contact PI
Oral Vaccination for AIDS Prevention in Rhesus Macaques$653,698
R01 · FY2010 · DE · contact PI
SIV DNA VACCINES AND MUCOSAL IMMUNITY$65,759
P51 · FY2010 · RR · contact PI
Oral Vaccination for AIDS Prevention in Rhesus Macaques$704,829
R01 · FY2009 · DE · contact PI
Nasal SIV vaccination in female macaques/AIDS prevention$506,970
R01 · FY2009 · AI · contact PI
Molecular mechanisms of cellular gene expression reprogramming by HIV Tat protein$392,994
R01 · FY2009 · AI · contact PI
SIV DNA VACCINES AND MUCOSAL IMMUNITY$111,945
P51 · FY2009 · RR · contact PI
Oral Vaccination for AIDS Prevention in Rhesus Macaques$627,652
R01 · FY2008 · DE · contact PI
Nasal SIV vaccination in female macaques/AIDS prevention$592,970
R01 · FY2008 · AI · contact PI
Molecular mechanisms of cellular gene expression reprogramming by HIV Tat protein$392,994
R01 · FY2008 · AI · contact PI
SIV DNA VACCINES AND MUCOSAL IMMUNITY$237,892
P51 · FY2008 · RR · contact PI
HIV and SIV DNA Vaccines and Mucosal Immunity$631,514
R56 · FY2007 · AI · contact PI
Nasal SIV vaccination in female macaques/AIDS prevention$610,682
R01 · FY2007 · AI · contact PI
Molecular mechanisms of cellular gene expression reprogramming by HIV Tat protein$400,606
R01 · FY2007 · AI · contact PI
SIV DNA VACCINES AND MUCOSAL IMMUNITY$190,553
P51 · FY2007 · RR · contact PI
Nasal SIV vaccination in female macaques/AIDS prevention$624,793
R01 · FY2006 · AI · contact PI
Molecular mech/gene expression reprogramming by HIV TAT$412,571
R01 · FY2006 · AI · contact PI
SIV DNA VACCINES AND MUCOSAL IMMUNITY$134,807
P51 · FY2006 · RR · contact PI
HIV and SIV Vaccines and Mucosal Immunity$667,992
R01 · FY2005 · AI
Nasal SIV vaccination in female macaques/AIDS prevention$636,599
R01 · FY2005 · AI
Molecular gene expression reprogramming by HIV TAT$413,600
R01 · FY2005 · AI
SIV DNA VACCINES AND MUCOSAL IMMUNITY$69,059
P51 · FY2005 · RR
HIV and SIV Vaccines and Mucosal Immunity$648,538
R01 · FY2004 · AI
Lentiviral modulation of gene expression in target cells$243,000
R21 · FY2004 · AI
SIV DNA VACCINES AND MUCOSAL IMMUNITY$64,424
P51 · FY2004 · RR
HIV and SIV Vaccines and Mucosal Immunity$634,388
R01 · FY2003 · AI
Lentiviral modulation of gene expression in target cells$242,250
R21 · FY2003 · AI
SIV DNA VACCINES AND MUCOSAL IMMUNITY$101,384
P51 · FY2003 · RR
HIV and SIV Vaccines and Mucosal Immunity$621,580
R01 · FY2002 · AI
RNA PROTEIN INTERACTIONS IN HIV RNA PACKAGING$283,274
R01 · FY2002 · AI
HIV and SIV Vaccines and Mucosal Immunity$568,895
R01 · FY2001 · AI
RNA PROTEIN INTERACTIONS IN HIV RNA PACKAGING$275,022
R01 · FY2001 · AI
HIV AND SIV DNA VACCINES AND MUCOSAL IMMUNITY$444,876
R01 · FY2000 · AI
HIV AND SIV DNA VACCINES AND MUCOSAL IMMUNITY$289,542
R01 · FY2000 · AI
RNA PROTEIN INTERACTIONS IN HIV RNA PACKAGING$267,010
R01 · FY2000 · AI